Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study.

Frontiers in immunology - 1 Jan 2021

Jiang Haihui, Yu Kefu, Cui Yong, Ren Xiaohui, Li Mingxiao, Yang Chuanwei, Zhao Xuzhe, Zhu Qinghui, Lin Song

Abstract excerpt

Background: World Health Organization (WHO) grade IV glioma remains one of the most lethal tumors with a dismal prognosis and inevitable recurrence. We evaluated the safety and efficacy of immunotherapy with radiotherapy in this population of patients. Methods: This study was a single-arm, open-label, phase I trial based on patients with recurrent WHO grade IV glioma. Patients were treated with intracranial and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Immunotherapy

Share to Killer Cells, Natural

Share to Neoplasm Recurrence, Local

Share to Radiotherapy

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 34025640
DOI: 10.3389/fimmu.2021.632547
PMCID: PMC8138184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study.PMID 34025640Read ↗

Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.Semantic proximity Read ↗

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trialsSemantic proximity Read ↗

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsSemantic proximity Read ↗

Prognostic utility of tumor grade and IDH-mutation status for immunotherapy response in high grade glioma: a systematic review and meta-analysis.Semantic proximity Read ↗

Assessment of Therapeutic Outcome and Role of Reirradiation in Patients With Radiation-induced GliomaSemantic proximity Read ↗

Outcomes of Salvage Fractionated Reirradiation Combined With Bevacizumab for Recurrent High-grade Gliomas That Progressed After Treatment With BevacizumabSemantic proximity Read ↗

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.Semantic proximity Read ↗

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.Semantic proximity Read ↗

Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaSemantic proximity Read ↗

Anlotinib plus Temozolomide for Recurrent Glioma: A Single-Center, Retrospective Study of 30 casesSemantic proximity Read ↗

Survival analysis of radiotherapy alone versus radiotherapy combined with temozolomide chemotherapy for low-grade gliomas: a meta-analysisSemantic proximity Read ↗

Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.